Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × vandetanib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Medullary 4 Neoplasm Metastasis 3 Thyroid Neoplasms 2 Recurrence 1 Neoplasms 1 Familial medullary thyroid carcinoma 1

Interventions

Rituximab 17 zanubrutinib 13 ibrutinib 10 venetoclax 7 Cyclophosphamide 6 Bendamustine Hydrochloride 6 pirtobrutinib 4 acalabrutinib 4 ixazomib 3 Specimen Handling 3 Sirolimus 3 Magnetic Resonance Spectroscopy 3 Lenalidomide 3 Dexamethasone 3 Bortezomib 3 Biopsy 3 fludarabine phosphate 2 Whole-Body Irradiation 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Etoposide 2 Cyclosporine 2 CT-P10 2 Blood Specimen Collection 2 ARQ531 2 talquetamab 1 selinexor 1 pomalidomide 1 pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡